文献速递脊柱关节炎类风湿关节炎

XCR1+经典1型树突状细胞通过IL-17A+CD8+T细胞加重骨性关节炎炎症

XCR1+ Conventional Type 1 Dendritic Cells Exacerbate the Inflammation in Osteogenic Arthritis Through IL-17A+CD8+ T Cells.
PubMed 文献 · Arthritis Rheumatol · 2026-02-09

该研究结合单细胞RNA测序、TCR分析、流式细胞术和多重免疫荧光,分析33例早期类风湿关节炎和强直性脊柱炎患者标本,发现cDC1在ERA关节中富集并高表达MHC I类抗原提呈,与CD8+T细胞强互作;在AS患者脊柱韧带中亦检测到cDC1。小鼠模型中cDC1和IL-17A+CD8+T细胞在韧带滑膜组织富集,中和XCL1阻断cDC1募集可缓解关节炎症状。结论为cDC1通过IL-17A+CD8+T细胞促进自身免疫反应和骨关节病变,靶向cDC1是骨重塑关节炎的新治疗靶点。

要点

  • cDC1在ERA关节和AS脊柱韧带中富集并高表达MHC I类抗原提呈。
  • cDC1与CD8+T细胞强互作,小鼠模型中IL-17A+CD8+T细胞在韧带滑膜组织富集。
  • 中和XCL1阻断cDC1募集可缓解小鼠关节炎症状。

核心结论

  • cDC1通过IL-17A+CD8+T细胞促进自身免疫反应和骨关节病变,靶向cDC1是骨重塑关节炎的新治疗靶点。

研究设计与样本

  • 研究对早期类风湿关节炎和AS患者标本进行单细胞RNA测序和TCR分析,并用流式细胞术和多重免疫荧光定量和定位免疫细胞亚群,共分析33例患者标本。
  • 研究利用versican来源肽联合II型胶原建立AS小鼠模型,在模型中进行免疫细胞定量、空间定位和靶向治疗。

主要发现

  • cDC1在ERA患者关节中富集,高表达MHC I类抗原提呈,与CD8+T细胞强互作。
  • 携带MHC I类抗原提呈分子的cDC1在AS患者脊柱韧带组织中检测到。
  • versican来源肽联合II型胶原可稳定高效诱导小鼠模型,表现附着点炎和异位骨化特征。
  • 小鼠模型中cDC1和IL-17A+CD8+T细胞在韧带滑膜组织高度富集。
  • 通过XCL1中和抗体阻断cDC1募集可缓解小鼠关节炎症状。

临床怎么用

  • 靶向cDC1或其募集分子XCL1可能成为骨重塑关节炎的新治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Ankylosing spondylitis (AS) and enthesitis-related arthritis (ERA) are autoimmune bone diseases characterized by prominent heterotopic ossification and both have poor prognoses. The pathologic mechanisms of these diseases remain poorly understood. METHODS: After single-cell RNA-sequencing and T cell receptor (TCR) profiling, we used flow cytometry and multiplex immunofluorescence to quantify and map specific immune-cell subsets within lesions of early rheumatoid arthritis and AS, analyzing a total of 33 patient specimens. Furthermore, we identified a peptide from versican, a chondroitin sulfate proteoglycan of ligament, to establish an AS mouse model. In the novel model, immune-cell quantification, spatial mapping, and targeted therapies were applied to elucidate the pathogenic roles of key cellular subpopulations. RESULTS: Conventional Type 1 dendritic cells (cDC1s) were enriched in the joints of patients with ERA and exhibited a high level of major histocompatibility complex (MHC) I antigen presentation, which robustly interact with CD8+ T cells. Moreover, cDC1s, harboring the molecular of MHC I antigen presentation, were detected in spinal ligament tissue of patients with AS. In mice, versican-derived peptide combined with Type II collagen stably and efficiently elicits a model exhibiting hallmark enthesitis and heterotopic ossification. In this model, cDC1s and IL-17A+CD8+ T cells were highly enriched in the ligamentous synovial tissues. Blocking the recruitment of cDC1s through XCL1-neutralizing antibody alleviates arthritis symptoms in vivo. CONCLUSION: Thus, cDC1s promote autoimmune reactions and osteoarticular lesions through IL-17A+CD8+ T cells. Targeting cDC1 represents a novel therapeutic target for bone remodeling arthritis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Shao F, Zhang S, Wu Z, et al. XCR1+ Conventional Type 1 Dendritic Cells Exacerbate the Inflammation in Osteogenic Arthritis Through IL-17A+CD8+ T Cells. Arthritis Rheumatol. 2026. PMID: 41640334. doi:10.1002/art.70069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。